OncLive® To Host State of the Science Summit™: Diagnosis, Management and Treatment of Multiple Myeloma

CRANBURY, N.J.--()--OncLive®, a leading digital provider of resources and information to oncology professionals, will present the State of the Science Summit™: Diagnosis, Management and Treatment of Multiple Myeloma, hosted at The Westin Charlotte, in Charlotte, North Carolina, on June 8, from 5:30-9 p.m. The summit, which follows the nation’s largest oncology meeting, will be chaired by Saad Z. Usmani, M.D., a hematologist and director of the Plasma Cell Disorder program and the director of Clinical Research in Hematologic Malignancies at Levine Cancer Institute /Carolinas Healthcare System. The program will also have presentations by multiple myeloma specialists and hematology experts from Levine Cancer Institute.

During this educational seminar, experts will discuss some of the most critical topics in the field of multiple myeloma such as, diagnosis and prognostication of multiple myeloma monoclonal gammopathy of undetermined significance and smoldering multiple myeloma, managing early relapses, and role of bone health and supportive care in multiple myeloma management. The program will conclude with a panel discussion, during which the attendees will have an opportunity to engage with following oncology experts:

  • Manisha Bhutani, M.D., is a hematology-medical oncology specialist and faculty member at the Levine Cancer Institute.
  • Reed Friend, M.D., serves as a hematology-medical oncology specialist at the Levine Cancer Institute.
  • Peter Voorhees, M.D., is an associate professor at School of Medicine in UNC – Chapel Hill, Clinical Research, Leukemia, Lymphoma, and Myeloma Program, UNC Lineberger Comprehensive Cancer Center.

State of the Science Summit™ is a premier conference series hosted by OncLive® with medical experts from across the nation. Aiming to discuss the current treatment options, the summit integrates academic and community-based physicians and healthcare professionals across key disciplines that range from medical and surgical oncology and hematology.

Complimentary drinks and dinner will be served during the reception. Registration is free and open to all health care professionals. For more information and for registration please visit www.onclive.com/meetings/soss or contact Allison Cooper at: ACooper@curetoday.com.

About OncLive®

A digital platform of resources for practicing oncologists, OncLive.com offers oncology professionals information they can utilize to help provide the best patient care. OncLive® is the official website for Michael J. Hennessy Associates’ Oncology Specialty Group, which publishes OncologyLive®, Oncology Nursing News®, Oncology Business Management™ and more. Michael J. Hennessy Associates, Inc. is a full-service health care communications company offering education, research, medical media, including curetoday.com and CURE® magazine, the largest U.S. consumer publication focused entirely on cancer. Combining science and humanity to make cancer understandable, CURE® reaches patients, cancer centers and advocacy groups.

Contacts

OncLive® Press:
Theresa Burek, 609-716-7777 ext. 811
tburek@mjhassoc.com
or
Surabhi Verma, 609-716-7777 ext. 851
sverma@mjhassoc.com

Release Summary

OncLive® To Host State of the Science Summit™: Diagnosis, Management and Treatment of Multiple Myeloma

Contacts

OncLive® Press:
Theresa Burek, 609-716-7777 ext. 811
tburek@mjhassoc.com
or
Surabhi Verma, 609-716-7777 ext. 851
sverma@mjhassoc.com